I don’t know how it is with you, but lupus has always been the disease that I hated the most. However, IgA nephropathy must be the one that I’m most frustrated about. Primarily, because I feel like there’s nothing I can do about it like I’m some kind of fraud just waiting for the patient to figure it all out and see straight through my incompetence. If you’re struggling with similar emotions, I strongly suggest that you listen to the IgA nephropathy podcast with our expert guest Professor Jonathan Barratt. Meet the man who boldly went where few have gone before to tackle this slow-paced monster and find solutions for all of us. 

Is it itching you to know more about CKD-associated pruritus? Do not worry! ERA is there for you!

Can you imagine that the number of patients with CKD-associated pruritus in your Unit is more important than your estimations?

Do you also have a bunch of patients that you do not know what to do with their itch?

In order to know this and many more on CKD-associated pruritus check out the new episode from A Pinch of Salt, a new podcast series by ERA created to answer clinically relevant questions on various subjects in nephrology. We are here to ask the embarrassing itching questions for you! Today’s guest is an eminent leader in CKD-associated pruritus, Dr Antoine Lanot from Caen, France.

In the latest episode of A Pinch of Salt check out 'Proteinuria - the common suspect', the most obvious whodunit in the pathophysiological process of kidney disease. Things are changing and I start being confused with the labile landscape of proteinuria. A huge number of mechanisms are presented and a large number of molecules are circulating or will circulate soon. In this pleasant tsunami of new ideas on the pathophysiologic mechanisms of proteinuria and the treatment options accompanying them, we’ll try to ask for help from the experts.

We‘ll start unfolding this complex network with the precious assistance of a leader in the subject Professor Annette Bruchfeld from  Linköping University, Sweden, the Chair of ERA Immunonephrology Working Group.

A Pinch of Salt today set sail very far away! We went to the other side of the Atlantic ocean, transversed a few thousand km or miles of land and finally got to Katherine Tuttle, from Washington USA, an eminent specialist on translational medicine who will « unconfuse » us on the « new drugs in nephrology » a series of innovative treatments or indications for currently existing ones. We‘ll talk about SGLT2 inhibitors, Mineralocorticoid receptor antagonists and many more! Because that's the objective of A Pinch of Salt! We are looking for common-sense answers to difficult clinically relevant questions. Our basic mission is to ask the questions a young nephrologist would want to ask at the ERA Congress but doesn’t have the guts to do so out of fear of appearing a simpleton. We firmly believe that the so-called “simple questions” may be the most important ones and are too rarely asked and answered. So join us for this most exciting exchange with an eminent specialist in the field.

Dialysis saves lives. But only if you can do it and do it well. Enter dialysis access. There is no dialysis without dialysis access. Whose job is it to take care of this vital, crucial part of dialysis? Is it OK to leave this to physicians for whom dialysis is not foremost in their minds? Or should it be the other way around? Should nephrologists become part-time surgeons? If you’re thinking about these things and particularly if you are harbouring a hidden desire to do some surgical stuff on top of being a brainiac day in and day out, then you simply must listen to the podcast that we did with Jernej Pajek, a well-known expert in the field of dialysis access, entitled – How to start a career in dialysis access.

How many times per day during your dialysis rounds do you find the personnel a bit stressed near a patient suffering from an episode of intradialytic hypotension?

And they are actually looking at you for the magic solution!

A lot of things are simultaneously passing from your mind but sometimes you are not absolutely sure if you are doing the right thing…

Despite the giant leaps of Nephrology in recent decades, intradialytic hypotension is still an important problem of daily practice affecting about 20% of hemodialysis patients. 

We feel that this is bad for the patients but we are not sure whether our acts and decisions are validated, whether they are the right ones.

So we’ll try to explore the options available with a world leader on the subject, Andrew Davenport from the University College of London, United Kingdom.